Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 5, 2018 4:00 P.M.
Form: S-3
CIK: 0001373707
Company Name: TETRAPHASE PHARMACEUTICALS INC
File Number: 333-222699